期刊文献+

高同型半胱氨酸血症与复发性脑梗死 被引量:17

Relationship between Hyperhomocysteinemia and Recurrent Cerebral Infarction
下载PDF
导出
摘要 目的 :探讨高同型半胱氨酸血症(HHcy)与复发性脑梗死 (RCI)的关系 ,为缺血性脑血管病的二级预防开辟新的预防和治疗途径。方法:将80例急性脑梗死患者 ,分为首发性脑梗死组 (FCI组 )43例 ,复发性脑梗死组(RCI组 )37例 ,利用高效液相色谱法测定空腹血浆同型半胱氨酸(tHcy)水平 ,并与40例健康者(对照组)对照研究。结果 :⑴空腹血浆tHcy 水平RCI组为 (23.96±6.07) μmol/L ,FCI组为 (21.61±4.72) μmol/L ,两组比较差别有统计学意义 (P<0.05)。⑵FCI组中HHcy14例 ,发生率32.56 % ;RCI组中HHcy17例 ,发生率45.95% ,正常对照组HHcy40例 ,发生率5 %。RCI组HHcy 的检出率显著高于FCI组 ,且2者检出率均显著高于对照组(均P<0.05)。⑶空腹血浆tHcy水平与RCI具有显著相关性 ,而与高血压病、血脂异常、糖尿病、吸烟及饮酒等RCI可能的危险因素无显著相关性 ,提示HHcy 可能是RCI的一个独立的危险因素。结论 :HHcy与RCI关系密切 ,可能为其一个独立的危险因素。 Objective:To study the relationship between hyperhomocysteinemia(HHcy)and recurrent cereˉbral infarction(RCI).Methods:Eighty patients with acute cerebral infarction(ACI)were divided into a first crebral infarction(FCI)group(n=43)and a RCI group(n=37),and40healthy people acted as control group.Results:⑴The levels of plasma fasting homocysteine in the RCI group(23.96±6.07)μmol/L was sigˉnificantly higher than that in the FCI group(21.61±4.72)μmol/L(P<0.05).⑵The incidence of HHcy in the RCI group(17/37,45.95%)was significantly higher than that in the FCI group(14/43,32.56%),and both of them were higher than the incidence of HHcy in the control group(2/40,5%)(all P<0.05).Conclusion:HHcy may be an independently risk factor that is associated with RCI.
出处 《天津医药》 CAS 北大核心 2003年第7期411-413,共3页 Tianjin Medical Journal
基金 天津市自然基金资助项目(项目编号:00360411)
关键词 高同型半胱氨酸血症 复发性脑梗死 危险因素 预防 治疗 cerebral infarction recurrence hyperhomocysteinemia risk factors
  • 相关文献

参考文献8

  • 1El Kossi MM, Zakhary MM. Oxidative stress in the context of acute cerebrovascular stroke. Stroke, 2000, 31 : 1889-92.
  • 2Li W, Zheng T, Wang J, et al. Extracellular magnesium regulates effects of vitamin B6, VB12 and folate on homocysteinemia- Induced depletion of Intracellular free megnesiumions In canine cerebral vascular smooth muscle cells: possible relationship to[Ca^2 + ] i, atherogenesis and stroke. Neurosci Lett, 1999,274 : 83- 6.
  • 3Kristensen B, Malm J, Nilsson TK, et al. Hyperhomocysteinemia and hypofibrinolysis in young adults with ischemic stroke. Stroke, 1999, 30: 974-80.
  • 4Andersson A, Brattstrom L, Israelsson B, et al. Plasma homocysteine before and after methionine loading with regard to age, gender and menopasal status. Eur J Clin Invest, 1992, 22:79-87.
  • 5The VITATOPS Trial Study Group. The VITATOPS(Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine - lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke. Cerebrovasc Dis, 2002, 13:120-6.
  • 6Woo KS, Chook P, Chan LL, et al. Long - term improvement in homocysteine levels and arterial endothelial function after 1 - year folic acid supplementation. Am J Med, 2002, 112(7) :535 - 9.
  • 7Van der Griend R, Haas Fj, Duran M, et al. Methionine loading test is necessary for detection of hyperhomocysteinemia. J Lab Clin Med, 1998, 132:67-72.
  • 8Shimizu H, Kiyohara Y, Kato I, et al. Plasma homoeyst(e)ine concentrations and the risk of subtypes of cerebral infarction. The hisayama study. Cerebrovase Dis, 2002, 13: 9- 15.

同被引文献180

引证文献17

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部